TR199903192T2 - Eritropoetin, de�i�tirilmi� hemoglobin i�eren farmasotik kombine m�stahzarlar. - Google Patents

Eritropoetin, de�i�tirilmi� hemoglobin i�eren farmasotik kombine m�stahzarlar.

Info

Publication number
TR199903192T2
TR199903192T2 TR1999/03192T TR9903192T TR199903192T2 TR 199903192 T2 TR199903192 T2 TR 199903192T2 TR 1999/03192 T TR1999/03192 T TR 1999/03192T TR 9903192 T TR9903192 T TR 9903192T TR 199903192 T2 TR199903192 T2 TR 199903192T2
Authority
TR
Turkey
Prior art keywords
preparations containing
erythropoietin
modified hemoglobin
combined preparations
containing erythropoietin
Prior art date
Application number
TR1999/03192T
Other languages
English (en)
Turkish (tr)
Inventor
Lehmann Paul
Town Michael-Harold
Feurstein Jurgen
Original Assignee
Roche Diagnostics Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roche Diagnostics Gmbh filed Critical Roche Diagnostics Gmbh
Publication of TR199903192T2 publication Critical patent/TR199903192T2/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/41Porphyrin- or corrin-ring-containing peptides
    • A61K38/42Haemoglobins; Myoglobins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06Antianaemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
TR1999/03192T 1997-06-21 1998-06-03 Eritropoetin, de�i�tirilmi� hemoglobin i�eren farmasotik kombine m�stahzarlar. TR199903192T2 (xx)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP97110168A EP0885613A1 (de) 1997-06-21 1997-06-21 Verwendung von modifizierten Hämoglobinen zur Behandlung von Anämien und Kombinationspräparate umfassend Erythropoietin und modifiziertes Hämoglobin

Publications (1)

Publication Number Publication Date
TR199903192T2 true TR199903192T2 (xx) 2000-05-22

Family

ID=8226937

Family Applications (1)

Application Number Title Priority Date Filing Date
TR1999/03192T TR199903192T2 (xx) 1997-06-21 1998-06-03 Eritropoetin, de�i�tirilmi� hemoglobin i�eren farmasotik kombine m�stahzarlar.

Country Status (15)

Country Link
US (3) US6440932B1 (https=)
EP (2) EP0885613A1 (https=)
JP (3) JP2002504913A (https=)
KR (1) KR100519904B1 (https=)
CN (1) CN1185010C (https=)
AT (1) ATE272405T1 (https=)
AU (1) AU743475B2 (https=)
BR (1) BR9810267A (https=)
CA (1) CA2294448C (https=)
DE (1) DE59811768D1 (https=)
DK (1) DK0996462T3 (https=)
ES (1) ES2226151T3 (https=)
PT (1) PT996462E (https=)
TR (1) TR199903192T2 (https=)
WO (1) WO1998058660A1 (https=)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT977582E (pt) * 1997-03-18 2002-12-31 Roche Diagnostics Gmbh Preparacoes farmaceuticas associadas contendo eritropoietina e preparacoes de ferro
US7345019B1 (en) * 1999-04-13 2008-03-18 The Kenneth S. Warren Institute, Inc. Modulation of excitable tissue function by peripherally administered erythropoietin
PL219131B1 (pl) * 2000-05-15 2015-03-31 Hoffmann La Roche Ciekła kompozycja farmaceutyczna, sposób jej wytwarzania oraz jej zastosowanie
CA2431964C (en) 2000-12-20 2013-09-10 F. Hoffmann-La Roche Ag Conjugates of erythropoietin (pep) with polyethylene glycol (peg)
US7767643B2 (en) 2000-12-29 2010-08-03 The Kenneth S. Warren Institute, Inc. Protection, restoration, and enhancement of erythropoietin-responsive cells, tissues and organs
US20030072737A1 (en) * 2000-12-29 2003-04-17 Michael Brines Tissue protective cytokines for the protection, restoration, and enhancement of responsive cells, tissues and organs
DE10215315A1 (de) * 2002-04-05 2003-11-20 Aventis Behring Gmbh Intellect Human-Transferrin zur Behandlung der Anaemia of Chronic Disease (ACD) und des funktionellen Eisenmangels
US7459435B2 (en) * 2002-08-29 2008-12-02 Hoffmann-La Roche Inc. Treatment of disturbances of iron distribution
US7459436B2 (en) * 2002-11-22 2008-12-02 Hoffmann-La Roche Inc. Treatment of disturbances of iron distribution
BRPI0414887A (pt) * 2003-09-29 2006-12-12 Warren Pharmaceuticals Inc E T métodos de tratamento, prevenção, retardo do inìcio ou redução dos efeitos de citocinas pró-inflamatórias em um mamìfero e de tratamento, prevenção, retardo do inìcio de uma condição associada com um efeito de citocinas pró-inflamatórias em um mamìfero, e, composição farmacêutica
RU2273485C2 (ru) * 2004-05-19 2006-04-10 Виктор Николаевич Алейников Железосодержащий препарат "феррал"
US7772182B2 (en) * 2004-08-05 2010-08-10 Alza Corporation Stable suspension formulations of erythropoietin receptor agonists
PL2054074T3 (pl) 2006-08-04 2015-03-31 Prolong Pharmaceuticals Llc Zmodyfikowana erytropoetyna
CL2008002053A1 (es) 2007-07-17 2009-05-22 Hoffmann La Roche Metodo para la purificacion de una eritropoyetina monopeguilada (epompeg) que consiste en proporcionar una solucion que contiene eritropoyetina mono, poli y no peguilada y hacerla pasar por dos pasos de cromatografia de intercambio cationico y metodo para producir epo mpeg que incluye metodo de purificacion.
CL2008002054A1 (es) * 2007-07-17 2009-05-29 Hoffmann La Roche Metodo para la regeneracion de una columna de cromatografia de intercambio cationico despues de la elusion de eritropoyetina monopeguilada y metodo para obtener una eritropoyetina monopeguilada, incorporando el metodo de regeneracion de la columna de intercambio cationico.
PT3380487T (pt) 2015-11-23 2020-10-29 Bristol Myers Squibb Co Sistemas de aditivos para utilização na peguilação de proteínas

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL77081A (en) 1984-12-04 1999-10-28 Genetics Inst Dna sequence encoding human erythropoietin process for the preparation thereof and a pharmaceutical composition of human erythropoietin
US4826811A (en) * 1986-06-20 1989-05-02 Northfield Laboratories, Inc. Acellular red blood cell substitute
NO881507D0 (no) * 1987-04-10 1988-04-07 Ortho Pharma Corp Fremgangsmaate for forhoeyning av hematokritnivaaet til et normalt pattedyr.
JPH03112934A (ja) * 1989-09-27 1991-05-14 Mitsubishi Kasei Corp 圧縮成型可能な粉体組成物
US5631219A (en) * 1994-03-08 1997-05-20 Somatogen, Inc. Method of stimulating hematopoiesis with hemoglobin
CA2180529A1 (en) * 1994-11-17 1996-05-30 John Blue Hemoglobin therapy in hemodialysis
DE19535571A1 (de) 1995-09-14 1997-03-20 Boehringer Mannheim Gmbh Pharmazeutische Kombinationspräparate und deren Verwendung zur Behandlung von Hämodialysepatienten
EP0939644B1 (en) * 1996-08-27 2004-01-14 Hemosol Inc. Enhanced stimulation of erythropoiesis

Also Published As

Publication number Publication date
JP5785008B2 (ja) 2015-09-24
EP0996462B1 (de) 2004-08-04
US6440932B1 (en) 2002-08-27
CN1185010C (zh) 2005-01-19
CN1261282A (zh) 2000-07-26
KR100519904B1 (ko) 2005-10-10
AU8109898A (en) 1999-01-04
AU743475B2 (en) 2002-01-24
JP2007246530A (ja) 2007-09-27
CA2294448C (en) 2007-12-11
ES2226151T3 (es) 2005-03-16
EP0996462A1 (de) 2000-05-03
DK0996462T3 (da) 2004-11-29
US20020160956A1 (en) 2002-10-31
WO1998058660A1 (de) 1998-12-30
KR20010014075A (ko) 2001-02-26
CA2294448A1 (en) 1998-12-30
PT996462E (pt) 2004-12-31
DE59811768D1 (de) 2004-09-09
EP0885613A1 (de) 1998-12-23
JP2011246474A (ja) 2011-12-08
US20050197281A1 (en) 2005-09-08
BR9810267A (pt) 2000-09-12
ATE272405T1 (de) 2004-08-15
JP2002504913A (ja) 2002-02-12

Similar Documents

Publication Publication Date Title
TR199903192T2 (xx) Eritropoetin, de�i�tirilmi� hemoglobin i�eren farmasotik kombine m�stahzarlar.
NZ236823A (en) Topical pharmaceutical and cosmetic compositions containing a salt of cholanic acid, a lipid and optionally a pharmaceutically or cosmetically active substance
ES2139678T3 (es) Uso de eritropoyetina para la preparacion de una composicion farmaceutica para administracion pulmonar o inhalacion.
AU2173988A (en) Stabilised human protein preparations
DK0582239T3 (da) Farmaceutisk og/eller kosmetisk formulering
ES2130428T3 (es) Cristales de insulina asp-b28.
EE9900075A (et) 7a-( -aminoalküül)östratrieenid, nende valmistamise meetod, 7a-( -aminoalküül)östratrieene sisaldavad farmatseutilised preparaadid ja nende kasutamine ravimite valmistamiseks
ATE223204T1 (de) Liposomenzusammensetzung
PT88539A (pt) Stabilisierung von therapeutisch wirksamen proteinen in pharmazeutischen zubereitungen
DE59707988D1 (de) Pharmazeutische kombinationspräparate enthaltend erythropoietin und eisenpräparate
CA2185883A1 (en) The use of dimeticone as a transport and carrier system and/or drug delivery system
EP0190860A3 (en) 6-chloro-3-methyl-1h-2,3,4,5-tetrahydro-3-benzazepine-n-oxide and medical compositions using it
DE59510583D1 (de) Pharmazeutische zusammensetzung zur systemischen transdermalen verabreichung mit dem wirkstoff morphin-6-glucuronid
IL85651A0 (en) Optically active oxo-isoindolinyl derivatives,their preparation and pharmaceutical compositions containing them
EP0418065A3 (en) Dihydrocaffeic acid derivatives, use thereof for medical treatments and pharmaceutical preparations containing same
ATE45956T1 (de) 11 beta-phenyl-gonane, deren herstellung und diese enthaltende pharmazeutische praeparate.
ATE78684T1 (de) Pharmazeutische loesung enthaltend salbutamol und cromoglycinsaeure.
TR199902305T2 (xx) Eritropoitein ve demir preperasyonları içeren farmasötik birleşimli preperasyonlar.